Hitachi Medical Systems America has received the Food and Drug Administration's 510(k) clearance to market its new SceptreP3 PET/CT system in the U.S. HMSA previewed the SceptreP3 at the 2004 Society of Nuclear Medicine (SNM) meeting in Philadelphia in June.
SceptreP3 includes dual attenuation correction (DAC technology), enabling the combination of both CT and sealed-source attenuation correction to effectively image patients with metal implants and prosthetics.
The system also features a nonrigid Fusion7D algorithm that provides image registration by correcting for respiration differences between PET and CT acquisitions. Integration of the Avia PACS architecture into SceptreP3 improves operational communication, multimodality connectivity, and scalable RAID archiving capabilities, according to Twinsburg, OH-based Hitachi.
By AuntMinnie.com staff writers
November 4, 2004
Related Reading
Hitachi to roll out new Ascent OS, September 22, 2004
Hitachi to release ultrasound upgrade, August 5, 2004
Hitachi to spotlight SceptreP3 PET/CT system, June 17, 2004
Cedara signs technology deal with Hitachi, April 6, 2004
Hitachi delivers PET isotope production system, January 22, 2004
Copyright © 2004 AuntMinnie.com
